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Polyclonal antiserum was prepared against phospholipase As from Naja naja and used to prepare a purified 
antibody. It cross-reacted with the antigen, and with intracellular mammalian PLA2. This antibody was im- 
munoreactive and inhibited the PLAl activity of Naja naja and of guinea pig alveolar macrophages or rat 
lymphocytes. By immunoblotting, this antiserum revealed one band of PLAl from Naja naja (14 kDa) and 
3 bands for guinea pig alveolar macrophages and rat lymphocytes (30, 45 kDa and a minor band of 14 
kDa). These results show an antigenic relatedness between an extracellular PLA2 and membrane-bound 
PLA2 from two different mammalian species and cell types. 
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1. INTRODUCTION 
Phospholipases As (EC 3.1.1.4) are present in 
most cells. Membrane-bound phospholipases AZ 
are involved in phospholipid turnover and in the 
release of arachidonic acid which is the limiting 
step of the arachidonate cascade [l-3]. These in- 
tracellular phospholipases As, in contrast with 
lysosomal phospholipases, are hydrophobic, re- 
quire calcium and have a neutral or alkaline op- 
timum pH [I]. As they represent a very small part 
of the cell proteins, only few of them have been 
purified to homogeneity [4]. Therefore, contradic- 
tory data have been reported about cell membrane 
phospholipases AZ, whereas extracellular enzymes 
such as phospholipase A2 from snake venom or 
pancreatic juice are well characterized in terms of 
amino acid sequence, 3-dimensional structure [2,5] 
and recently mRNA sequence [6]. 
Secreted phospholipases A2 share common 
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properties with membrane-bound intracellular 
phospholipases AZ (calcium and pH requirement) 
although their biological functions are completely 
different. Contradictory results have been reported 
about their antigenic relatedness. Meijer et al. [7] 
failed to show any detectable cross-reactivity be- 
tween polyclonal antibodies directed against pan- 
creatic phospholipase AZ and venom phos-+ 
pholipases. No immunological relationship was 
found by Wurl and Kunze [8] between human 
seminal and pancreatic phospholipases AZ. Con- 
versely, Okamoto et al. [9] observed an antigenic 
cross-reactivity between an antiserum prepared 
against rat pancreatic phospholipase AZ and rat 
spleen microsomal phospholipase AZ. Using 
several monoclonal antibodies directed against rat 
liver mitochondrial phospholipase AZ, De Jong et 
al. [lo] observed a cross-reactivity with rat liver 
cytosol or rat platelet phospholipase A2 but not 
with rat or pig pancreatic phospholipase A2 nor 
with Crotalus atrox phospholipase AZ. Recently, 
Khalil et al. [l l] reported the inhibition of snake 
venom and porcine pancreatic phospholipases A2 
by a monoclonal antibody generated against 
human plasma lecitin-cholesterol acyltransferase, 
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which acts both as phospholipase AZ and as 
acyltransferase. 
The present study reports the cross-reaction of a 
polyclonal antibody prepared against Naja naja 
phospholipase AZ with membrane-bound phos- 
pholipases AZ from different mammalian cell types 
and species. 
2. MATERIALS AND METHODS 
2.1. Anti-Naja naja phospholipase A2 antibody 
Naja naja venom phospholipase A2 (grade V, 
Sigma, St. Louis, MO) was purified by 
polyacrylamide gel electrophoresis in the presence 
of SDS and /3-mercaptoethanol according to 
Laemmli [12]. Phospholipase AZ bands were cut, 
pooled and homogenized. After emulsification 
with Freund’s complete adjuvant, they were in- 
jected into rabbit. Booster injections were ad- 
ministered at 2, 4, 6 and 8 weeks. Antiserum 
samples were titrated by ELISA procedure. In all 
experiments we used the material collected after 9 
weeks and stored at -20°C. Immunoglobulin G 
(IgG) was purified from the antiserum by gel exclu- 
sion chromatography on a column of DEAE 
cellulose (DE 52 Whatman). A further purification 
on a Trisacryl-Blue column (Pharmacia) was per- 
formed to eliminate the albumin-bound 
phospholipase A2 inhibitor described in rabbit 
plasma [13]. IgG purification was controlled by 
electrophoresis and IgG was concentrated in 
dialysis tubing embedded in polyethylene glycol 
20 M. 
2.2. Phospholipase A2 activity 
Phospholipase A2 from Naja naja was tested 
using di-[ 1-r4C]palmitoyl phosphatidylcholine 
(95 mCi/mmol, Amersham) diluted with dipal- 
mitoyl phosphatidylcholine (Sigma) as substrate. 
Incubations were carried out for 20 min at 37°C 
under agitation in 1 ml of 50 mM Tris buffer (pH 
9) containing 16 PM substrate, 10 mM calcium and 
6 ng of phospholipase. 
Membrane-bound phospholipase A2 from 
guinea pig pulmonary alveolar macrophage (PAM) 
was solubilized by 1 M NaCl as described by 
Colard-Torquebiau et al. [14] and measured using 
dioleyl phosphatidyl [1-r4C]ethanolamine (60 
mCi/mmol, Amersham) diluted with phosphati- 
dylethanolamine (Sigma) as substrate. NaCl ex- 
12 
tracts were prepared from PAM harvested as 
described [15]. After differential adhesion, the 
cells were scraped in 50 mM Tris buffer (pH 8) 
containing 1 M NaCl, then sonicated twice for 15 s 
using a MSE sonifier. After a 30 min incubation at 
room temperature, the lysate was centrifuged at 
30000 x g for 20 min. The supernatant was 
recovered and used as NaCl extract. PAM 
phospholipase activity was assayed by incubating, 
for 15 min at 37”C, 60 pg of NaCl extract proteins 
in 1 ml of 50 mM glycine-NaOH buffer (pH 8.5) 
with 8 PM substrate and 2 mM calcium. NaCl ex- 
tract from rat lymphocytes was prepared and its 
phospholipase activity assayed as described [ 161. 
In order to test the inhibition of phospholipase 
A2 activities by the anti-Naja naja phospholipase 
A2 antibody, enzyme samples from Naja naja or 
macrophage and lymphocyte NaCl extracts were 
preincubated with the appropriate dilution of an- 
tibody for 10 min at 37°C. The phospholipase ac- 
tivity was then assayed as described above. 
At the end of the incubation, lipids were ex- 
tracted [17] and separated by thin layer 
chromatography on silica gel plates using 
chloroform : methanol :water (65 : 25 : 4, v/v). 
Spots were revealed by iodine vapor, scraped off 
and radioactivity measured with a Kontron scin- 
tillation counter. 
2.3. Western blotting 
Electrophoresis was performed according to 
Laemmli [ 121. Samples of Naja naja 
phospholipase A2 or of macrophages and lym- 
phocyte NaCl extracts were preincubated for 1 h at 
37°C in 0.5 M Tris buffer (pH 6.8) containing 
20% sucrose, 0.05% bromophenol blue and 1.8% 
SDS. Standards were preincubated for 2 min at 
95°C in the same buffer containing 5% ,& 
mercaptoethanol. Western immunoblotting was 
done according to Burnette. [18]. Electrophoretic 
transfer onto the nitrocellulose papers was carried 
out for 90 min at a constant voltage of 40 V in 
25 mM Tris base buffer (pH 8.3) containing 
0.192 M glycine. The antigen-antibody complex 
was revealed with “‘I-protein A (700000 cpm/ml) 
for 1 h. 
3. RESULTS AND DISCUSSION 
As shown in fig.lA, the polyclonal antibody 
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generated against the Naja naja phospholipase AZ 
inhibited the activity of its own antigen. The 50% 
inhibition of the activity (I&-J was obtained with 
5 ,eg of antibody; 20 pg induced an almost com- 
plete inhibition. We could exclude any effect of the 
albumin-bound phospholipase A2 inhibitor 
previously described in rabbit serum [13] because 
the antibody was purified to eliminate albumin. 
Furthermore, the preimmune rabbit antibody 
prepared in the same conditions did not inhibit Na- 
ja naja phospholipase AZ activity (fig.lA). 
band was detected neither by the antiserum prein- 
cubated with an excess of antigen (fig.lB, lane b) 
nor by the preimmune serum (fig.lB, lane c). 
Taken together, these data established the 
specificity of the polyclonal antibody that we 
prepared against Naja naja phospholipase AZ. 
Immunoblotting of Naja naja phospholipase A2 
showed a single band of apparent molecular mass 
of 14 kDa revealed by the anti-Naja naja 
phospholipase AZ antiserum (fig.lB, lane a). This 
In a second step, we studied the cross-reactivity 
of this antibody towards mammalian phospho- 
lipase A2 preparations. We found that the anti- 
Naja naja phospholipase A2 antibody inhibited the 
phospholipase A2 activity of NaCl extracts from 
guinea pig PAM (fig.2A). The ICSO was reached 
for 13 /Ig of antibody whereas preimmune an- 
tibody did not decrease the phospholipase AZ ac- 
tivity. A similar inhibition curve was observed with 
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Fig. 1. Inhibition and immunoblotting detection of Baja 
nuja phospholipase AZ. (A) Inhibition of Nuju naja 
phospholipase A2 activity as a function of antibody 
concentration: after preincubation for 10 min at 37°C 
with the anti-Nuju nuja phospholipase A2 antibody 
(close circles) or preimmune antibody (open circles), 
phospholipase A2 was assayed as described in the text. 
Results are expressed as percentages of the initial activity 
of the enzyme (34.6 f 2.7 ymol of fatty acids released 
per min and mg protein of Naja naja phospholipase). (B) 
Immunoblotting detection of phospholipase Az from 
Naja nuju (0.1 rg) with the anti-Naja nuju 
phospholipase Az antiserum (lane a), the same antiserum 
pretreated with a large excess of antigen (lane b) or 
preimmune serum (lane c). After the 12% 
polyacrylamide gel electrophoresis and the transfer 
September 1987 
procedure, nitrocellulose bands were revealed 
500-fold diluted antiserum. Molecular masses 
determined by comparison with standards. 
with 
were 
13 
Volume 222, number I FEBS LETTERS September 1987 
,‘I-rc-i 
10 20 30 lie 
pg ANTIBODY 
Volume 222, number 1 FEBS LETTERS September 1987 
NaCl extracts from rat lymphocytes (not shown). Table 1 
By immunoblotting of NaCl extracts from either 
guinea pig PAM or rat lymphocytes, the antiserum 
revealed two major bands of apparent M, 30000 
and 45000 and a minor band of A4,14000 (fig.2B, 
lanes a and d). These three bands were only weakly 
stained with Coomassie blue, indicating that they 
did not correspond to major proteins of the NaCl 
extract. As for Naja naja phospholipase AZ, these 
bands were not revealed neither with the antiserum 
previously incubated with a large excess of its an- 
tigen (fig.2B, lanes b and e) nor with the preim- 
mune serum (fig.2B, lanes c and f). These results 
meant that the antiserum reacted with these three 
bands. A molecular mass of 14 kDa has been 
reported for cellular phospholipase AZ isolated 
from different tissues and species [l-3] but Apitz- 
Castro et al. [ 191 found a 44 kDa phospholipase A2 
in human platelets. Furthermore, dimeric and 
monomeric phospholipases A2 have been evi- 
denced in Crotafus snake venom [20]. As we ob- 
tained the same migration with NaCl extracts 
treated with or without fl-mercaptoethanol before 
electrophoresis, the question remains of whether 
these bands correspond to different polymeric 
forms of the same enzyme or to different cellular 
phospholipases AZ. 
Interspecies reactivity of the anti-Naja naja 
phospholipase A2 antibody 
Naja naja Guinea-pig Rat lympho- 
phospho- PAM cyte (NaCl 
lipase A2 (NaCl extract) 
extract) 
50% inhibition 
of PLA2 
activity 5 13 24 
50% of maxi- 
mal reactivity 
by ELISA 8 34 60 
Results are expressed as pg of antibody responsible for 
the 50% inhibition of phospholipase A2 activity or 
giving the half of maximal immunoreactivity assayed by 
ELISA. Phospholipase A2 activity was measured with 
6 ng of Naja naja phospholipase A2 or 60 tg of guinea- 
pig PAM and rat lymphocyte NaCl extract. ELISA was 
performed with 10 pug of Naja naja phospholipase A2 or 
50 pg of cobaye macrophage and rat lymphocyte NaCl 
extracts 
In table 1 we have compared the ICSO and the 
half-maximal reactivity by ELISA for Naja naja 
phospholipase A2 and NaCl extracts of guinea pig 
PAM and rat lymphocytes. We observed that the 
three preparations displayed the same ratio be- 
tween their ICSO and half-maximal reactivity. In 
addition our antibody cross-reacted with a 
phospholipase A2 purified from human placenta 
(Jordan, L., personal communication). 
antibodies directed against a rat liver mitochon- 
drial phospholipase AZ, showed an intraspecies 
cross-reactivity with cellular phospholipases AZ but 
neither intraspecies nor interspecies reactivity with 
extracellular phospholipases AZ. Moreover these 
antibodies had no inhibitory effect on any of the 
phospholipases A2 they tested. 
Previous data demonstrated either an in- 
traspecies relatedness between a secretory and a 
cellular phospholipase A2 [9] or an interspecies 
relatedness between secretory enzymes [ 1 I]. 
Recently, De Jong et al. [lo], using monoclonal 
Our results clearly demonstrated an interspecies 
relatedness between a polyclonal antibody 
prepared against a secretory phospholipase AZ and 
mammalian cellular phospholipase A2 from guinea 
pig PAM and rat lymphocytes. This relatedness is 
expressed by immunoreactivity as well as by inhibi- 
tion of the phospholipase A2 activity. 
Fig.2. Inhibition and immunoblotting detection of phospholipase A2 from guinea-pig PAM and rat lymphocytes. (A) 
Inhibition of the phospholipase A2 from guinea-pig PAM as a function of antibody concentration by polyclonal 
antibody against Naja naja (closed circles) or preimmune antibody (open circles). The initial activity was 0.49 + 
0.06 nmol of fatty acids released per min and mg proteins of 1 M NaCl extract from guinea-pig PAM. For procedure, 
see fig. 1. (B) Immunoblotting detection of phospholipase A2 from guinea-pig PAM (50 pg proteins of NaCl extract, 
lanes a, b and c) and rat lymphocyte (5Oyg proteins of NaCl extract, lanes d, e and f) by the polyclonal antiserum 
prepared against Naja naja phospholipase A2 (lanes a and d), the same antiserum pretreated with a large excess of Naja 
naja phospholipase A2 (lanes b and e) or preimmune serum (lanes c and f). The procedure is described in fig.1. 
15 
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